Phase
Condition
Dermatitis, Atopic
Skin Infections/disorders
Hives (Urticaria)
Treatment
ATI-2138
Clinical Study ID
Ages 18-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Able to comprehend and willing to sign the IRB approved ICF/assent prior toadministration of study-related procedures.
Male patients or non-pregnant, non-nursing female patients 18 to 60 years old,inclusive, at the time of informed consent/assent.
Have at least a 1-year history of moderate or severe AD prior to the ScreeningVisit, and no significant AD flares for the 4 weeks prior to the Screening Visit asdetermined by the Investigator upon review of participant medical history.
Exclusion
Exclusion Criteria:
Any prior exposure to systemic (oral) JAK inhibitors or TYK inhibitors at any timeprior to Screening.
Unstable course of AD (spontaneously improving or rapidly deteriorating) based onthe patient history or as determined by the investigator during the ScreeningPeriod.
Refractory AD (ie, AD that required frequent hospitalizations and/or frequentintravenous treatment for skin infections within the year before the ScreeningVisit).
Concomitant skin disease or clinically infected AD or presence of other skin diseasein the area to be dosed that may interfere with study assessments.
Female patients who are pregnant, nursing, or planning to become pregnant during thestudy.
Study Design
Study Description
Connect with a study center
Aclaris Investigational Site
Birmingham, Alabama 35244
United StatesSite Not Available
Aclaris Investigational Site
Encino, California 91436
United StatesSite Not Available
Aclaris Investigational Site
San Diego, California 92123
United StatesSite Not Available
Aclaris Investigational Site
Plainfield, Indiana 46168
United StatesSite Not Available
Aclaris Investigational Site
Austin, Texas 78759
United StatesSite Not Available
Aclaris Investigational Site
San Antonio, Texas 78213
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.